Incidence and type of tumors induced in C57BL bg/bg mice and +/bg littermates by oral administration of DMBA
- 15 December 1981
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 28 (6) , 739-746
- https://doi.org/10.1002/ijc.2910280613
Abstract
As an attempt to study the effect of the beige (bg) mutation on chemical carcinogenesis, 64 C57Bl/bg/bg mice and 83 +/bglittermate controls received DMBA in five weekly intragastric doses. The incidence of tumors of different histological types was monitored through observation periods ranging between 165 and 500 days. By 165 days after the first DMBA feeding, 18% of the +/bg and 31% of the bg/bg mice had developed tumors. The beige mice had a higher incidence of epithelial and non‐epithelial tumors arising in cutaneous or subcutaneous sites than the controls. The total incidence of lymphomas was similar in the two groups. However, lymphomas appeared somewhat earlier in beige than in control mice. Altogether 33 +/bg and 27 bg/bg mice were followed for 500 days. By this time, 73% of the +/bg and 78% of the bg/bg mice had developed tumors. The beige group showed a higher incidence of non‐thymic lymphomas than the controls. In contrast, the incidence of thymic lymphoma, cutaneous epithelial tumors and bile‐duct adenomas was similar in the two groups or higher in +/bg than in bg/bg mice. The results suggest that the bg mutation causes a certain defect in a mechanism that may prevent or delay the onset of nonthymic lymphomas and of epithelial and non‐epithelial cutaneous tumors in DMBA‐treated mice. The differences between the two groups were smaller than those previously reported in relation to the increased susceptibility of beige mice to certain transplanted tumors, attributed to the known defect in natural killer (NK) activity in the beige mice. The reduced differential in the DMBA system may be due to the partial reduction of NK activity, induced by the carcinogen, as reported previously (Ehrlich et al., 1980) and confirmed in the present study.This publication has 26 references indexed in Scilit:
- In vitro NK-activity andin vivo resistance to leukemia: Studies of beige, beige/nude and wild-type hosts on C57BL backgroundInternational Journal of Cancer, 1980
- Genetic control of sensitivity to Moloney leukemia virus in mice. III. The three H‐2‐linked Rmv genes are immune response genes controlling the antiviral antibody responseEuropean Journal of Immunology, 1980
- NATURAL CELLULAR REACTIVITIES MEDIATED BY SPLENOCYTES FROM MICE BEARING THREE TYPES OF PRIMARY TUMORInternational Journal of Cancer, 1980
- Chediak-Higashi gene in humans. I. Impairment of natural - killer functionThe Journal of Experimental Medicine, 1980
- Augmentation of mouse natural killer activity and induction of interferon by tumor cells in vivo.The Journal of Experimental Medicine, 1980
- Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient miceNature, 1980
- Spontaneous and Induced Preleukemia Cells in C57BL/6 Mice: Brief Communication2JNCI Journal of the National Cancer Institute, 1978
- Resistance ofH-2 heterozygous mice to parental tumorsImmunogenetics, 1977
- Xeroderma PigmentosumAnnals of Internal Medicine, 1974
- THE CHEDIAK-HIGASHI SYNDROMEMedicine, 1972